AKT1 and breast carcinoma: In the context of cancer CAMKK2 has been associated with development of prostate cancer, activation of AKT signalling in ovarian cancer, and regulation of immune microenvironment in breast cancer (Gocher et al., 2017; Penfold et al., 2018; Racioppi et al., 2019).